Skip to content

Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis

Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03282253
Enrollment
216
Registered
2017-09-13
Start date
2018-01-01
Completion date
2019-06-30
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis, Organ Failure, Multiple

Brief summary

In this study, the investgatiors aimed to investigate the associations between serum levels of stearoyl-CoA desaturase-1(SCD-1) and the disease severity as well as the presence of adverse clinical events, such as local complications, organ failure, mortality and so on.In this prospective study, participants were divided into two groups based on serum SCD-1 concentration on admission and prospectively observe the disease severity and clinical outcomes of them.

Interventions

None listed

Sponsors

Nanjing University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Diagnosis of acute pancreatitis (Atlanta standard), abdominal pain occurred within one week of admission; 2. APACHEII score is more than 8 and Ranson score is greater than 3; 3. Age 18-75; 4. Obtaining informed consent.

Exclusion criteria

1. Pregnancy pancreatitis; 2. Patients with the following disease history: severe cardiac, pulmonary, renal, liver function insufficiency or immunodeficiency disease.

Design outcomes

Primary

MeasureTime frame
the incidence rate of infected pancreatic necrosis2-4 week after disease onset

Secondary

MeasureTime frameDescription
the incidence rate of organ failure1-2 week after disease onsetthe incidence rate of organ failure (transient or persistent)
the incidence rate of local complications1-2 week after disease onsetacute peripancreatic fluid collections, pancreatic pseudocycts, acute necrotic collections and walled-off necrosis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026